id: NEW:oat_treatment_access_to_NEW:oat_preference_alignment
name: Opioid Agonist Therapy Treatment Access â†’ OAT Preference-Treatment Alignment
from_node:
  node_id: NEW:oat_treatment_access
  node_name: Opioid Agonist Therapy Treatment Access
to_node:
  node_id: NEW:oat_preference_alignment
  node_name: OAT Preference-Treatment Alignment
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Expanded access to diverse OAT options enables treatment matching'
- 'Step 2: Patients receiving preferred medication type show higher satisfaction'
- 'Step 3: Higher proportion of buprenorphine recipients (92%) preferred their current medication compared
  to methadone recipients (77%)'
- 'Step 4: Preference-aligned treatment may improve retention and outcomes'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: M J Stowe et al. 2026. "Factors Associated With Preferences for Opioid Agonist Therapies
    Among People Dependent on Opioids.." https://doi.org/10.1111/dar.70079
  supporting_citations:
  - Additional citations require full-text access
  doi: 10.1111/dar.70079
  citation_verified: true
  needs_manual_review: true
  citation_issues:
  - 'Year mismatch: DOI shows 2025, source is 2026'
last_updated: '2025-12-06'
version: '2.0'
description: Among those receiving OAT, a significantly higher proportion of buprenorphine recipients
  (92%) preferred their current medication compared to methadone recipients (77%), suggesting differential
  satisfaction and potential need for expanded treatment options.
quantitative_effects:
  sample_size: 400
spatial_variation:
  varies_by_geography: true
  variation_notes: Study notes need for expanded access to OAT in Australia, suggesting geographic variation
    in treatment availability
moderators:
- name: current_oat_type
  direction: strengthens
  strength: strong
  description: 92% of current buprenorphine recipients preferred their medication vs 77% of methadone
    recipients
structural_competency:
  equity_implications: This mechanism highlights structural barriers to patient-centered care in OAT.
    When healthcare systems limit medication options, patients may receive treatments that do not align
    with their preferences, potentially affecting engagement and outcomes. The study calls for expanded
    take-home options and treatment variety as structural solutions.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.156523'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
